Spots Global Cancer Trial Database for histone deacetylase inhibitors
Every month we try and update this database with for histone deacetylase inhibitors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer | NCT01090830 | Non-Small-Cell ... | Belinostat, car... | 18 Years - | Holy Cross Hospital, Florida | |
| Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer | NCT01090830 | Non-Small-Cell ... | Belinostat, car... | 18 Years - | Holy Cross Hospital, Florida | |
| LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors | NCT01159418 | Advanced Solid ... | Panobinostat (L... | 18 Years - 75 Years | Southern Europe New Drug Organization | |
| A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL) | NCT01238692 | Diffuse Large B... | LBH589 Rituximab | 18 Years - | Jewish General Hospital | |
| Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer | NCT02115594 | Breast Cancer | Fulvestrant Entinostat Placebo | - | Syndax Pharmaceuticals | |
| Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer | NCT02115594 | Breast Cancer | Fulvestrant Entinostat Placebo | - | Syndax Pharmaceuticals | |
| A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | NCT00926640 | Carcinoma Neuro... Small Cell Lung... Malignant Epith... | Belinostat Cisplatin Etoposide | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma | NCT01583283 | Multiple Myelom... | ACY-1215 lenalidomide Dexamethasone | 18 Years - | Celgene | |
| A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | NCT00926640 | Carcinoma Neuro... Small Cell Lung... Malignant Epith... | Belinostat Cisplatin Etoposide | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | NCT02897778 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Neoplasm... Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Placebo | 18 Years - | Syndax Pharmaceuticals | |
| Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma | NCT01583283 | Multiple Myelom... | ACY-1215 lenalidomide Dexamethasone | 18 Years - | Celgene | |
| A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL) | NCT01238692 | Diffuse Large B... | LBH589 Rituximab | 18 Years - | Jewish General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
